Court Rejects J&J Bid For Injunction In Amgen Case
A federal judge in New Jersey has rejected Johnson & Johnson's request for a preliminary injunction against Amgen's marketing practices for anemia drug Aranesp in the ongoing antitrust battle between the...To view the full article, register now.
Already a subscriber? Click here to view full article